Type 2 diabetes and cardiovascular risk: Lessons from therapeutic trials;Diabète de type 2 et risque cardiovasculaire: Enseignements des essais thérapeutiques

Revue du Praticien

Volumn 51, Issue 16, 2001, Pages 1793-1799

  Lievre M ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ASASANTINE; DIPYRIDAMOLE; INSULIN; METFORMIN; RAMIPRIL; SULFINPYRAZONE; SULFONYLUREA; TICLOPIDINE;

CARDIOVASCULAR RISK; DIABETES CONTROL; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; RISK FACTOR; RISK MANAGEMENT; SECONDARY PREVENTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; META-ANALYSIS; OBESITY; PLATELET AGGREGATION INHIBITORS; PRIMARY PREVENTION; PROSPECTIVE STUDIES; RAMIPRIL; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; TIME FACTORS;

EID: 0035887281     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. A program for the meta-analysis of clinical trials
2. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. III Clinical implication of UGDP results
3. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV a preliminary report on phenformin results
4. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
5. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
6. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
7. Efficacy of diuretics and beta-blockers in diabetic hypertensive patients: Results from a meta-analysis
8. Randoraised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
9. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
10. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
11. Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NIDDM
12. Morbidity and mortality in patients randomised to double-blind treatment with long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
13. Randomised trial of effects of calcium antagonists compared with diuretics and b-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study
14. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
15. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPP) randomised trial
16. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
17. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
18. Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia
19. Gemfibrozil for the secondary prevention of coronary heart disease in men with Iow levels of high-density lipoprotein cholesterol
20. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
21. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/Tex-CAPS
22. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S)
23. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
24. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
25. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
26. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in high-risk patients
27. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus. Results of the HOPE study and MICRO-HOPE substudy